Leukemia Treatment in Israel
Leukemia is the most common blood malignancy among children, although adults can also be afflicted with this life-threatening disease. It is a cancer of the blood, including the bone marrow and lymphatic system. Leukemia symptoms can be severe and devastating. In general, the bone marrow in people with leukemia produces abnormal white blood cells, which do not work properly to fight infection
There are many types of leukemia, which require different treatment approaches. The treatment can be complicated – conventional therapies, such as radiation and chemotherapy, are not always successful. In Israel, leukemia treatments are provided with a comprehensive and customized approach, based on cutting-edge research and years of professional experience. Our highly trained medical experts offer new and progressive options that are unavailable in other countries, such as CAR-T cell therapy, which can only be obtained in a handful of clinics in the USA.
Benefit from Progressive Leukemia Treatments in Israel
Leukemia treatment depends on a number of factors, which is why Israeli medical teams apply a collaborative approach. Hematologists, oncologists, and radiation oncologists evaluate every individual’s case, using advanced diagnostics and high-tech techniques.
Leukemia treatments in Israel include:
- Chemotherapy – drugs that use chemicals to kill cancer cells
- Radiation therapy – X-rays or high-energy beams are used to stop the growth of cancer cells
- Stem cell transplants – replaces diseased bone marrow with healthy bone marrow
- Immunotherapy – biological treatments that help the immune system to attack cancer cells, such as CAR-T Cell Therapy
Types of Leukemia & How They Are Treated
The type of leukemia will largely determine which treatment is most suitable.
Acute Lymphoblastic Leukemia (ALL)
This aggressive cancer is the most common form of leukemia in children, and it can also occur in adults. Usually, treatment involves chemotherapy, and hospitals in Israel offer the latest approved drugs with strict safety standards. If treatment can bring ALL into remission, stem cell transplants may then be conducted. Radiation therapy may also be used in combination with chemotherapy, and immunotherapy is another promising option.
Chronic Lymphocytic Leukemia (CLL)
This is the most common adult leukemia, and it progresses very slowly. It is also much rarer than ALL. The first step to designing an effective treatment for CLL is to diagnose the type of leukemia precisely. Many state-of-the-art diagnostic technologies, such as full cytogenetic profiles, are available in Israel, along with a top-tier staff of experts. Conventional chemotherapy or targeted chemotherapy are the primary methods of treatment for CLL. Other possibilities include radiation therapy and immunotherapy.
Survivors of Leukemia Treatment in Israel: Heartwarming Stories
Ivan Egorov – A Young Boy from Russia
Ivan was diagnosed with leukemia in Russia when he was only 23 months old. He spent the next four months in the hospital, receiving high-dose chemotherapy. After the first results were positive, his parents’ next step was to find the best international medical center to perform his bone marrow transplant. Yulia Egorova, Ivan’s mother, researched extensively before she booked a consultation at Sheba Medical Center in Israel.
“Immediately upon our arrival in Israel,” says Yulia, “the doctors took a blood sample for crossmatch testing … they inspired my trust, and I never doubted their professionalism … The doctors, nurses, and medical coordinators were brilliant and supportive. Two months later,
Ivan received his bone marrow transplant at Sheba, and my son now has his whole life ahead of him to live.”
Mylène – Lifesaving CAR-T Treatment for a Swiss Teen
At 15 years old, Mylène was diagnosed with ALL and began five months of intensive chemotherapy in Switzerland, only to suffer a relapse during that same year. She had a very resistant type of leukemia that generally has a poor prognosis. Further treatments of chemotherapy and biopharmaceutical drugs were unable to bring her into complete remission, and eventually her leukemia spread – becoming extramedullary, a worst-case scenario.
At this point, cutting-edge CAR-T Cell therapy was recommended as her only hope. After Mylène’s family researched where to receive innovative CAR-T therapy, they discovered that it was available at Sheba Medical Center in Israel, at an affordable price. About one month after her arrival in Israel, Mylène underwent CAR-T Cell therapy. After about seven weeks of specialized care from the experts at Sheba, she finally overcame her progressive resistant leukemia and was able to return home. CAR-T Cell therapy saved her life.
“Without our exceptional medical team in Israel, we would never have survived this turning point in our life … Both medical competency and compassion abound at Sheba Medical Center,” said Mylène’s family.
Why Choose Sheba Medical Center for Leukemia Treatment in Israel?
- Multidisciplinary and holistic care from a team of oncologists, radiation oncologists, hematologists, nurses, and support staff
- First-rate medical specialists, many of whom have trained at the MD Anderson Cancer Center in Texas
- Constant collaboration with research and clinical centers around the world to ensure that patients receive the latest treatments
- Affordable and transparent costs, with no hidden fees
- Massive campus with all-inclusive facilities – all treatments are provided under one roof
- Efficient care and clear communication by the supportive staff of our International Medical Tourism Division